Lhasa Limited shared knowledge shared progress
Home > Library > Search the Library > QSAR 2021 Is the bacterial reverse mutation assay an accurate predictor for N-nitrosamine carcinogenicity
Publications
  • Highlighted Item:
  • Publisher:
    Lhasa Limited
  • Publication Date:
    JUN 2021
  • Reference:
  • DOI:
  • PMID:
  • Publication Type:
    Poster
  • Related Products:
    Vitic NexusVitic
  • Scientific Area:
    Mutagenic Impurities
  • Endpoint:
    • Carcinogenicity
    • Mutagenicity
  • Industry Type:
    Pharmaceutical
  • Related event:
    2021 QSAR

QSAR 2021 Is the bacterial reverse mutation assay an accurate predictor for N-nitrosamine carcinogenicity

pdf filePonting DJ; Tennant R; Thresher A;

Dr. David Ponting, Lhasa Senior Scientist presented this poster titled "Is the bacterial reverse mutation assay an accurate predictor for N-nitrosamine carcinogenicity?" at the International Workshop on (Quantitative) Structure-Activity Relationships in Environmental and Health Sciences. This poster focuses on Lhasa’s use of extensive data, curated in Vitic to investigate claims in older literature that the Ames test may not be adequate for nitrosamine carcinogenicity.

Download

Related Publications

  • Linked In
  • Twitter

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.